chenodeoxycholic acid has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, LA; Bikle, DD; Bogart, JW; Cook, JM; Preston, JV; Sanchez, LM; Silvaggi, NR; Teske, KA; Yu, OB | 1 |
Choi, YH; Im, EO; Jin, Y; Kim, ND; Suh, H; Yoo, YH | 1 |
2 other study(ies) available for chenodeoxycholic acid and Cancer of Prostate
Article | Year |
---|---|
Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
Topics: Calcitriol; Cell Line, Tumor; Cholesterol; Glucuronates; Humans; Lithocholic Acid; Male; Prostatic Neoplasms; Receptors, Calcitriol; Transcription, Genetic; Vitamin D; Vitamin D3 24-Hydroxylase | 2016 |
Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells.
Topics: Apoptosis; Blotting, Western; Caspases; Cell Cycle; Cell Cycle Proteins; Chenodeoxycholic Acid; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA-Binding Proteins; DNA, Neoplasm; Dose-Response Relationship, Drug; E2F Transcription Factors; E2F1 Transcription Factor; Humans; Indoles; Luciferases; Male; Phosphorylation; Poly(ADP-ribose) Polymerases; Precipitin Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Retinoblastoma Protein; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ursodeoxycholic Acid | 2003 |